Form 4: Sotera Health Director Christopher Simon Granted Over 19,000 Restricted Stock Units

Sotera Health Co. Director Christopher Simon was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's 2020 Omnibus Incentive Plan.

Summary

• Christopher Simon, a Director of Sotera Health Co. (SHC), acquired 19,132 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on May 22, 2025.
• These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock.
• The RSUs will vest in full on the earlier of the first anniversary of the grant date or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on Mr. Simon's continued service as a non-employee director.
• The acquisition price for these RSUs was $0.
• Following this transaction, Mr. Simon beneficially owns 19,132 shares directly.

Sentiment

Score: 6

Explanation: The grant of RSUs to a director is a positive for aligning interests, but it's a routine compensation event and not indicative of significant new operational or financial performance.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Christopher Simon aligns his interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• The transaction is part of the established Sotera Health Company 2020 Omnibus Incentive Plan, indicating a structured approach to executive and director compensation.

Future Outlook

The vesting conditions for the RSUs indicate a future commitment from the director, with full vesting expected on the earlier of the first anniversary of the grant date or the date immediately prior to the next annual shareholders meeting, subject to continued service.

Industry Context

This is a routine equity compensation grant to a non-employee director, common practice across industries to align director interests with shareholder value. Sotera Health operates in the healthcare sterilization and lab services sector.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to non-employee directors is a standard practice in corporate governance across various industries, including healthcare and specialized services, to incentivize long-term commitment and align interests with shareholders.
• The vesting schedule, tied to either a one-year anniversary or the next annual meeting, is typical for director equity grants, similar to practices observed in companies like Steris plc (STE) or Cantel Medical (now part of STERIS), which also operate in sterilization and infection prevention.

Corporate Governance

Related Party Transactions

• The RSU grant is a transaction between the company and a director, which is a related party transaction, but it is a standard compensation mechanism disclosed as such.

Stakeholder Impact

• Shareholders: Positive impact due to increased alignment of director's interests with shareholder value through equity ownership.

Next Steps

• The RSUs are subject to vesting conditions, which will occur on the earlier of May 22, 2026 (first anniversary of grant) or the date immediately prior to Sotera Health's next regular annual shareholders meeting.

Key Dates

Recommendation

Keywords

Sotera Health, SHC, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Christopher Simon, Omnibus Incentive Plan